Metoprolol Improves Endothelial Function in Patients with Cardiac Syndrome X
Author | Maryam Majidinia | en |
Author | Yousef Rasmi | en |
Author | Mohammad Hassan Khadem Ansari | en |
Author | MirHossein Seyed-Mohammadzad | en |
Author | Ehsan Saboory | en |
Author | Alireza Shirpoor | en |
Issued Date | 2016-07-31 | en |
Abstract | Endothelial dysfunction which is manifested by the loss of nitric oxide bioavailability, is an increasingly recognized cause of cardiac syndrome X (CSX) and beta blockers are used for the treatment of this syndrome. Thus, the aim of this study was to investigate effects of metoprolol, as a beta blocker, on endothelial function in CSX patients. | en |
DOI | https://doi.org/10.22037/ijpr.2016.1869 | en |
Keyword | Metoprolol | en |
Keyword | Endothelial function | en |
Keyword | Cardiac syndrome X | en |
Keyword | Angiography | en |
Keyword | Nitric oxide | en |
Publisher | Brieflands | en |
Title | Metoprolol Improves Endothelial Function in Patients with Cardiac Syndrome X | en |
Type | Original Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ijpr-15-561.pdf
- Size:
- 513.58 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF